Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +63.65% | +52.89% | -70.21% | +33.28% | -12.61% |
| Gross Profit Growth | +73.26% | +59.56% | -70.21% | +20.76% | -12.61% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.83% | +2.44% | +2.50% | +1.82% | +1.59% |
| Weighted Average Shares Diluted Growth | +1.83% | +2.44% | +2.50% | +1.82% | +1.59% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | -83.06% | -83.20% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -35.52% | -36.01% | -43.30% | -52.79% | -63.02% |
| Book Value per Share Growth | -98.03% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -8.26% | -15.47% | -25.56% | -42.66% | -92.72% |
| R&D Expense Growth | -51.51% | +3.68% | -1.85% | -5.96% | -17.71% |
| SG&A Expenses Growth | -20.88% | -8.27% | -22.79% | -29.40% | -36.10% |